Christian E. Elling
Christian E. Elling leads Lundbeckfonden’s early-stage, evergreen biotech investment unit Lundbeckfonden Emerge.
He is a member of the board of directors of SNIPR Biome, IO Biotech, NMD Pharma and Afyx Therapeutics. He is the former CEO of Insusense Therapeutics and former member of the board of directors of Folium Science, EpiTherapeutics and Inagen. Christian was previously co-founder, Vice President of Biology and Development and later CEO of 7TM Pharma. Christian received his early training in biochemistry and received his PhD in pharmacology from University of Copenhagen, Denmark.